Aruni Tennakoon is a programmer/Analyst at University of Manitoba. She has expertise in computer programming and statistical methods. Aruni received her M.Sc. (Statistics) from Simon Fraser University, British Columbia and M.Sc. (Mathematics) from University of Sri Jayewardenepura, Sri Lanka. She has been working on IBD research projects since 2013. Other than that, Aruni has working experience in research projects related to Multiple Sclerosis in MB and BC provinces, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Chlamydia. She enjoys taking on new challenging projects, learning new methods and sharing her knowledge with others.

Recent published papers:

  • Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population–Based Analysis The American Journal of Gastroenterology: January 2020 - Volume 115 - Issue 1 - p 128-137
  • Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study Inflammatory Bowel Diseases, Volume 26, Issue 1, January 2020
  • The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease Inflammatory Bowel Diseases, Volume 25, Issue 10, October 2019
  • Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study Clinical Gastroenterology and Hepatology Volume 17, Issue 9, August 2019